Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for RDSNF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 3.679M
March 31, 2026 3.696M
December 31, 2025 3.719M
September 30, 2025 3.819M
June 30, 2025 3.794M
March 31, 2025 3.728M
December 31, 2024 3.583M
September 30, 2024 3.455M
June 30, 2024 2.848M
March 31, 2024 1.861M
December 31, 2023 2.292M
September 30, 2023 2.195M
June 30, 2023 2.279M
March 31, 2023 2.677M
December 31, 2022 2.606M
Date Value
September 30, 2022 2.544M
June 30, 2022 3.137M
March 31, 2022 3.803M
December 31, 2021 4.141M
September 30, 2021 4.447M
June 30, 2021 4.811M
March 31, 2021 8.215M
December 31, 2020 8.913M
September 30, 2020 1.249M
June 30, 2020 1.609M
March 31, 2020 1.526M
December 31, 2019 1.597M
September 30, 2019 0.9579M
June 30, 2019 0.1369M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Elekta AB 767.30M
Surgical Science Sweden AB 470.22M
Senzime AB 27.26M
Acarix AB 4.523M
Accuray, Inc. 41.70M

Shareholders Equity (Quarterly) Related Metrics